APN, a kind of adipokine derived from adipocytes, has the function of improving systemic insulin sensitivity, promoting glucose and lipid metabolism, and lowering blood glucose, and its dysregulation is implicated in the pathogenesis of DCM [78]. This evidence concerns the gene ANPEP and familial dilated cardiomyopathy.